Fuente: FierceBiotech After a tumultuous tenure marked by recent clashes with the biopharma industry, Vinay Prasad, M.D., will be departing his post as the FDA’s top regulator of vaccines and cell and gene therapies at the end of April, an agency spokesperson confirmed to Fierce Biotech.